Medicine and Dentistry
Placebo
100%
Memantine
87%
Therapeutic Procedure
62%
Adverse Event
50%
Positive and Negative Syndrome Scale
50%
Atypical Antipsychotic
25%
Placebo-Controlled Study
25%
Antagonist
25%
Clinical Global Impression
25%
Patient
25%
Inpatient
25%
Observation
25%
Study Participant
12%
Neurotransmission
12%
Cognition
12%
Alzheimer's Disease
12%
Aspartic Acid
12%
Physical Examination
12%
Evaluation Study
12%
Glutamate Receptor
12%
Extrapyramidal Symptoms
12%
Calgary Depression Scale
12%
Laboratory
12%
Incidence
12%
Amaurosis
12%
Adjuvant Therapy
12%
Neuroscience
Memantine
87%
Dementia Praecox
75%
Placebo
75%
Negative Syndrome
50%
Positive Syndrome
50%
Atypical Antipsychotic
25%
Cognition
25%
Neurotransmission
12%
Extrapyramidal Symptoms
12%
Depression
12%
Glutamate Receptor
12%
Aspartic Acid
12%
Physical Examination
12%
Pharmacology, Toxicology and Pharmaceutical Science
Memantine
87%
Schizophrenia
62%
Adverse Event
50%
Atypical Antipsychotics
25%
Placebo-Controlled Study
25%
Extrapyramidal Symptoms
12%
Alzheimer Disease
12%
Aspartic Acid
12%
Glutamate Receptor
12%
Incidence
12%
Blindness
12%
Psychology
Schizophrenia
75%
Treatment
62%
Groups
37%
Assessment
25%
Alzheimer's Disease
12%
Depression Scale
12%
Glutamate
12%
Evaluation
12%
Neurotransmission
12%
INIS
symptoms
62%
patients
50%
safety
25%
evaluation
12%
laboratories
12%
data
12%
assessments
12%
therapy
12%
nervous system diseases
12%
receptors
12%
mems
12%